Immune Design Corp. (IMDZ) Return on Investment ROI from the fourth quarter of 2018 to fourth quarter of 2017 and for the year 2018, average high and low, overall ranking from Dec 31 2018 to Dec 31 2017 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Immune Design Corp.  (IMDZ)


Immune Design.'s ROI from its fourth quarter of 2018 to the fourth quarter of 2017 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Immune Design.'s ROI in the fourth quarter of 2018?
Immune Design Corp. recorded a cumulative net loss of $-55 million during 12 months ending in the fourth quarter of 2018, resulting in a negative return on investment (ROI) of -49.5%.

Within the Healthcare sector 458 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2018 from 0 to 4256.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Investment Change TTM 22.67 % 54.65 % 23.51 % 7.58 % -7.51 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 92 105 117 129 139
Return On Investment (TTM) -49.5 % -43.4 % -46.9 % -51.95 % -57.51 %
IMDZ's Overall Ranking # 4256 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -9.64 % 9.36 % 10.68 % 12.15 % 13.92 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -55 -53 -53 -53 -52

IMDZ Company Profile >> Back to IMDZ Roi Comparisons >> See Annual IMDZ Return On Investment



Return On Investment IMDZ's Ranking
Within: No.
Industry # 211
Sector # 459
Overall # 4256

Return On Investment Statistics
High Average Low
-12.36 %
-42.89 %
-68.63 %
(Mar 31 2015)   (Sep 30 2017)







Financial Statements
Immune Design.'s IV. Quarter Investments $ 92 Millions IMDZ's Balance sheet
Immune Design.'s IV. Quarter Income $ -14 Millions Quarterly IMDZ's Income Statement
IMDZ's Income by Division See IMDZ's Income by Division


IMDZ Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Investments in Millions 92 139 95 109 66
Y / Y Investment Growth -33.88 % 46.29 % -12.66 % 64.12 % -
Net Income in Millions -55 -52 -54 -39 -34
Y / Y Net Income Growth - - - - -
Annual Return On Investment -59.45 % -37.23 % -56.21 % -36.18 % -51.4 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IMDZ's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IMDZ's Competitors
Subscribers only: Roi for Immune Design.'s Suppliers
Subscribers only: Return On Investment for IMDZ's Customers

Other Ratios
IMDZ's Roa IMDZ's Inventory Turnover Ratio IMDZ's Growth Rates IMDZ's Dividend Statistics
IMDZ's Profitability Ratios IMDZ's Asset Turnover Ratio IMDZ's Dividend Growth
IMDZ's Roe IMDZ's Valuation Ratios IMDZ's Financial Strength Ratios IMDZ's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2018, within Healthcare Sector ROI

Date modified: 2026-09-05T14:00:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.